Want to see QTEX full AI Analyst Report?
QTEX Stock Chart & Stats
$0.96
-$0.05(-4.95%)
At close: 4:00 PM EST
$0.96
-$0.05(-4.95%)
Day’s Range― - ―
52-Week Range$0.28 - $3.85
Previous CloseN/A
VolumeN/A
Average Volume (3M)330.47K
Market Cap
$55.35M
Enterprise Value$4.62M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$640.00K
Price to Earnings (P/E)―
Beta3.47
Next Earnings
Aug 06, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding43,579,260
10 Day Avg. Volume227,613
30 Day Avg. Volume330,466
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)11.48
Price to Sales (P/S)92.25
P/FCF Ratio-2.68
Enterprise Value/Market Cap0.08
Enterprise Value/Revenue15.99
Enterprise Value/Gross Profit2.31K
Enterprise Value/Ebitda-0.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.1
Revenue Forecast (FY)$48.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Cryogenic IPA provisional patent on a cryogenic interconnect architecture builds durable IP that addresses core scaling challenges in superconducting quantum systems. Proprietary materials‑driven designs raise barriers to entry, support licensing or product differentiation, and can underpin long‑term customer engagement.
Commercial Customer WinsWinning qualified orders from a government customer and a Fortune 500 enterprise demonstrates product validation and early commercial traction. Delivery and in‑house production capability show the company can convert R&D into revenue, help build repeatable sales, and open channels to larger, higher‑margin programs.
Acquired AME Assets & ScaleAcquiring AME product lines and related assets materially expands manufacturing capacity, customer relationships and IP. The vertical integration can accelerate commercialization, reduce time‑to‑market for component products, and create cross‑sell and scale benefits that persist beyond near‑term cycles.
Bears Say
Severe Cash BurnConsistent multi‑million dollar negative operating and free cash flow indicates structural cash burn requiring repeated external financing. This limits strategic flexibility, increases dilution risk, and can force prioritization of short‑term survival over investments needed to scale production and close larger commercial contracts.
Minimal, Unstable RevenueVery small and volatile revenue prevents operating leverage and undermines margin improvement. Without a clear, repeatable revenue base, R&D and manufacturing investments may not translate to sustainable cash generation, keeping losses persistent and making long‑term commercial forecasting unreliable.
Sustained Losses & Balance Sheet StrainMaterial equity erosion and recurring net losses have pressured the balance sheet and led auditors to note going‑concern risks. This raises refinancing and counterparty risk, may constrain large program commitments, and increases the chance that future growth is contingent on further dilutive financing or strategic transactions.
QTREX Quantum Ltd News
QTEX FAQ
What was QTREX Quantum Ltd’s price range in the past 12 months?
QTREX Quantum Ltd lowest stock price was $0.28 and its highest was $3.85 in the past 12 months.
What is QTREX Quantum Ltd’s market cap?
QTREX Quantum Ltd’s market cap is $55.35M.
When is QTREX Quantum Ltd’s upcoming earnings report date?
QTREX Quantum Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 16 days.
How were QTREX Quantum Ltd’s earnings last quarter?
QTREX Quantum Ltd released its earnings results on Mar 26, 2026. The company reported -$0.21 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$0.01.
Is QTREX Quantum Ltd overvalued?
According to Wall Street analysts QTREX Quantum Ltd’s price is currently Overvalued.
Does QTREX Quantum Ltd pay dividends?
QTREX Quantum Ltd does not currently pay dividends.
What is QTREX Quantum Ltd’s EPS estimate?
QTREX Quantum Ltd’s EPS estimate is -0.03.
How many shares outstanding does QTREX Quantum Ltd have?
QTREX Quantum Ltd has 43,579,260 shares outstanding.
What happened to QTREX Quantum Ltd’s price movement after its last earnings report?
QTREX Quantum Ltd reported an EPS of -$0.21 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went down -23.092%.
Which hedge fund is a major shareholder of QTREX Quantum Ltd?
Currently, no hedge funds are holding shares in QTEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
QTREX Quantum Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.28%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-33.82%
Trailing 12-Months
Company Description
QTREX Quantum Ltd
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
Technical Analysis
Ownership Overview
6.84% Insiders
<0.01% Mutual Funds
0.47% Other Institutional Investors
92.59% Public Companies and Individual Investors